Cite
HARVARD Citation
Awan, M. et al. (2016). Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: what is the role for surgery?. Expert review of anticancer therapy. 16 (11), pp. 1131-1144. [Online].